Hospital-acquired Pneumonia Clinical Trial
To rapidly adapt or deescalate the initially broad antibiotic treatment, an antibiogram analysis is required. E test strips have successfully provided an antibiogram 24 h after having been directly applied to bronchoalveolar lavage (BAL). An open-label, prospective cohort study of consecutive patients with hospital-acquired pneumonia will be conducted with the aim of validating a new method increasing the rapidity of antibiogram analysis compared to standard methods of culture. This antibiogram will be provided by E test strips directly applied to bronchoalveolar lavage (BAL) samples and analyzed from the 6th up to the 24th hour after its completion. The occurrence of major errors (S with E test method, I or R with standard method) and minor errors (I or R with E test method and S with standard method)will be observed and a comparison of H6, H10 and H24 results performed.
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06168734 -
Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP
|
Phase 3 | |
| Not yet recruiting |
NCT01940731 -
Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults
|
Phase 2 | |
| Not yet recruiting |
NCT06028217 -
Chinese Hospital Acquired Pneumonia Collaboration Network: Epidemiology, Diagnosis and Treatment
|
||
| Completed |
NCT01561469 -
Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin
|
N/A | |
| Terminated |
NCT00543608 -
Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia
|
Phase 2 | |
| Enrolling by invitation |
NCT04055922 -
Comparison of Solid Organ Transplant
|
||
| Completed |
NCT04403971 -
0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia
|
N/A | |
| Completed |
NCT04774094 -
Efficacy and Safety of Ceftazidime-Avibactam (CAZ-AVI) in Chinese Participants With HAP (Including VAP)
|
Phase 4 | |
| Completed |
NCT05060718 -
HOspital NEtwork STudy - Preparation for a Randomized Evaluation of Anti-Pneumonia Strategies
|
||
| Active, not recruiting |
NCT05785442 -
Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia
|
Phase 2 | |
| Completed |
NCT04700202 -
Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care Unit
|
||
| Not yet recruiting |
NCT05418517 -
Hospital Acquired Pneumonia in Temporary Tracheostomy
|
||
| Recruiting |
NCT04381247 -
Comprehensive Molecular Diagnosis and Management of Hospital- and Ventilator-associated Pneumonia in Norway
|
||
| Recruiting |
NCT05483309 -
Feasibility Study of Contemporary Diagnostics for Patients With Suspected Hospital-Acquired Pneumonia.
|
N/A | |
| Completed |
NCT04937075 -
Impact of Antimicrobial Stewardship on Outcomes of Patients With Hospital-acquired Pneumonia Due to Gram-negative Bacilli - A Before-after Study
|
||
| Completed |
NCT03496220 -
Effect of Angulus on Patient-elevation Compliance
|
N/A | |
| Not yet recruiting |
NCT05914584 -
"Baricitinib for Treating Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype.
|
Phase 2/Phase 3 | |
| Completed |
NCT05663905 -
Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients
|
Phase 4 | |
| Terminated |
NCT03361085 -
Modular Prevention Bundle for Non-ventilator-associated Hospital-acquired Pneumonia (nvHAP)
|
N/A | |
| Completed |
NCT05624684 -
Diagnostic Performance and Impact of a Multiplex PCR Pneumonia Panel in ICU Patients With Severe Pneumonia.
|